Digest Network Come funziona
Network
/
Società
No
Non verificato

Novartis Pharma AG

Di cosa scriviamo

Annunci EconomiciFarmaceuticaManagement/Organizzazione AziendaleMedicina Salute BenesserePubblicità/Marketing/Media/Comunicazione

68 comunicati stampa

Guarda tutti i comunicati
24/11/2025
Farmaceutica
Annunci Economici
Novartis data underscore pioneering scientific innovation in Hematology and Oncology at ASH and SABCS
Fonte
Novartis Pharma AG
Emittente
GLOBENEWSWIRE
1.00
0
24/11/2025
Farmaceutica
Medicina Salute Benessere
Annunci Economici
Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)
Fonte
Novartis Pharma AG
Emittente
GLOBENEWSWIRE
1.00
0
19/11/2025
Farmaceutica
Annunci Economici
Novartis projects +5-6% cc sales CAGR 2025-2030, with long-term growth backed by 30+ potential high-value pipeline assets
Fonte
Novartis Pharma AG
Emittente
GLOBENEWSWIRE
1.00
0
19/11/2025
Farmaceutica
Annunci Economici
Novartis announces plans to build flagship manufacturing hub in North Carolina
Fonte
Novartis Pharma AG
Emittente
GLOBENEWSWIRE
1.00
0
12/11/2025
Farmaceutica
Annunci Economici
Novartis Phase III trial for next-generation malaria treatment KLU156 (GanLum) meets primary endpoint, with potential to combat antimalarial resistance
Fonte
Novartis Pharma AG
Emittente
GLOBENEWSWIRE
1.00
0
10/11/2025
Farmaceutica
Medicina Salute Benessere
Annunci Economici
Novartis opens new radioligand therapy manufacturing facility in California as part of $23B US expansion plan
Fonte
Novartis Pharma AG
Emittente
GLOBENEWSWIRE
1.00
0
03/11/2025
Farmaceutica
Annunci Economici
New Novartis data at ASN Kidney Week and AHA Scientific Sessions demonstrate momentum of broad CRM portfolio and pipeline
Fonte
Novartis Pharma AG
Emittente
GLOBENEWSWIRE
1.00
0
29/10/2025
Farmaceutica
Annunci Economici
Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials
Fonte
Novartis Pharma AG
Emittente
GLOBENEWSWIRE
1.00
0
28/10/2025
Farmaceutica
Annunci Economici
Novartis completes acquisition of Tourmaline Bio
Fonte
Novartis Pharma AG
Emittente
GLOBENEWSWIRE
1.00
0
27/10/2025
Farmaceutica
Annunci Economici
Novartis announces expiration of Tourmaline Bio tender offer 
Fonte
Novartis Pharma AG
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0